Effects of Azithromycin on Shiga Toxin Production by Escherichia coli and Subsequent Host Inflammatory Response

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2002-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.46.11.3478-3483.2002PMID 12384353PMCID PMC128727
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protective effect of anisodamine against Shiga toxin-1: inhibition of cytokine production and increase in the survival of mice.

  2001cited by this paper
• American Gastroenterological Association. Our new president--Jon I. Isenberg, M.D.

  2001cited by this paper
• Modulation of host cell signalling by enteropathogenic and Shiga toxin-producing Escherichia coli.

  2001cited by this paper
• Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.

  2000cited by this paper
• Complete nucleotide sequence of the prophage VT1-Sakai carrying the Shiga toxin 1 genes of the enterohemorrhagic Escherichia coli O157:H7 strain derived from the Sakai outbreak.

  2000cited by this paper
• Macrolide antibiotics as biological response modifiers.

  2000cited by this paper
• A Novel Hemagglutinin of Enterohemorrhagic Escherichia coli 086:NM Associated with Hemolytic Uremic Syndrome in a Child

  2000cited by this paper
• Current Concepts and Management

  2000cited by this paper
• Pathogenesis, treatment, and therapeutic trials in hemolytic uremic syndrome.

  1999cited by this paper
• Induction of Prophages of EnterohemorrhagicEscherichia coli O157:H7 with Norfloxacin

  1999influential reference
• Recombinational Repair of DNA Damage inEscherichia coli and Bacteriophage λ

  1999cited by this paper
• Sequence of Shiga Toxin 2 Phage 933W fromEscherichia coli O157:H7: Shiga Toxin as a Phage Late-Gene Product

  1999cited by this paper
• Recombinational repair of DNA damage in Escherichia coli and bacteriophage lambda.

  1999cited by this paper
• Effect of clarithromycin and azithromycin on production of cytokines by human monocytes.

  1999cited by this paper
• Complete nucleotide sequence of the prophage VT2-Sakai carrying the verotoxin 2 genes of the enterohemorrhagic Escherichia coli O157:H7 derived from the Sakai outbreak.

  1999cited by this paper
• Diarrheagenic Escherichia coli

  1998cited by this paper
• Structure, biology, and relative toxicity of Shiga toxin family members for cells and animals

  1998influential reference
• Escherichia coli O157 interactions with human intestinal Caco-2 cells and the influence of fosfomycin.

  1998cited by this paper
• Inhibitory Effect of Erythromycin on Interleukin 8 Production by 1α,25-Dihydroxyvitamin D3-Stimulated THP-1 Cells

  1997cited by this paper
• Secretion of IL-1 beta, TNF-alpha, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria.

  1997cited by this paper
• Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis.

  1997cited by this paper
• Inhibitory effect of erythromycin on interleukin 8 production by 1 alpha,25-dihydroxyvitamin D3-stimulated THP-1 cells

  1996cited by this paper
• Regulation of the Shiga-like toxin II operon in Escherichia coli

  1996cited by this paper
• Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release.

  1996cited by this paper
• Tumor necrosis factor concentrations in hemolytic uremic syndrome patients and children with bloody diarrhea in Argentina.

  1995cited by this paper
• Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura

  1995cited by this paper
• Consensus conference statement: Escherichia coli O157:H7 infections--an emerging national health crisis, July 11-13, 1994.

  1995cited by this paper
• Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C.

  1995cited by this paper
• Hemolytic‐uremic syndrome and enterohemorrhagic Escherichia coli

  1994cited by this paper
• A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome.

  1993cited by this paper
• Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells.

  1991cited by this paper
• Induction of β-lactamase and methicillin resistance in unusual strains of methicillin-resistant Staphylococcus aureus

  1990cited by this paper
• Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release.

  1990cited by this paper
• The pharmacokinetics of azithromycin in human serum and tissues.

  1990cited by this paper
• Shiga-like toxin converting phage of enterohemorrhagic Escherichia coli strain 933.

  1989cited by this paper
• Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin.

  1987cited by this paper
• Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin.

  1987cited by this paper
• The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

  1985cited by this paper
• Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea.

  1984cited by this paper
• Hemorrhagic colitis associated with a rare Escherichia coli serotype.

  1983cited by this paper
• Hemolytic-Uremic Syndrome: Current Concepts and Management

  1982cited by this paper
• [Hemolytic-uremic syndrome].

  1973cited by this paper
• Committee Report

  1969cited by this paper

• Epidemiology of Bloody Diarrhea, Shiga Toxin-producing Escherichia coli and Hemolytic Uremic Syndrome in Children.

  2026cites this paper
• Co-resistance and plasmid-mediated co-dissemination of florfenicol and azithromycin resistance in non-O157 Shiga toxin-producing Escherichia coli from cattle in Xinjiang, China

  2025cites this paper
• Role of phage therapy in acute gastroenteritis

  2025cites this paper
• Antibiotic-Mediated Prophage Activation: Mechanisms, Consequences, and Therapeutic Implications.

  2025cites this paper
• Molecular Detection and Antibiotic Susceptibility Pattern of Shiga Toxin-Producing Escherichia coli among Children with Diarrhea in Addis Ababa, Gondar, and Harar, Ethiopia

  2025cites this paper
• Bloody diarrhea, STEC infection, and HUS in the molecular microbiology era

  2025cites this paper
• Shiga Toxin–Producing Escherichia coli–Associated Hemolytic Uremic Syndrome in Adult Kidney Transplant Recipients

  2025cites this paper
• Do asymptomatic STEC-long-term carriers need to be isolated or decolonized? New evidence from a community case study and concepts in favor of an individualized strategy

  2024cites this paper
• Hemolytic uremic syndrome following complicated appendicitis in a child: what is the missing link?

  2021cites this paper
• Azithromycin Resistance in Shiga Toxin-Producing Escherichia coli in France between 2004 and 2020 and Detection of mef(C)-mph(G) Genes

  2021cites this paper
• Risk of Hemolytic Uremic Syndrome Related to Treatment of Escherichia coli O157 Infection with Different Antimicrobial Classes

  2021cites this paper
• Therapeutic Uses of Bacterial Subunit Toxins

  2021cites this paper
• Use of the Multiplex Diagnostic PCR Panel in Diarrheal Disease: Expert Guidance on the Interpretation of Results With a Focus on Travelers' Diarrhea.

  2020cites this paper
• Therapeutic Strategies to Protect the Central Nervous System against Shiga Toxin from Enterohemorrhagic Escherichia coli

  2020cites this paper
• Shiga-Toxin E. coli Hemolytic Uremic Syndrome: Review of Management and Long-term Outcome

  2020cites this paper
• Guideline for the Antibiotic Use in Acute Gastroenteritis

  2019cites this paper
• Multiplex PCR reveals a high prevalence of multiple pathogens in traveller’s diarrhoea in children

  2018cites this paper
• Syndromes hémolytiques et urémiques (SHU) et syndromes de microangiopathie thrombotique apparentés : traitement et pronostic

  2017cites this paper
• [Hemolytic and uremic syndrome and related thrombotic microangiopathies: Treatment and prognosis].

  2017cites this paper
• Conduite à tenir en cas de gastroentérites à Escherichia coli entérohémorragique (EHEC)

  2016cites this paper
• Editorial Commentary: Increasing Evidence That Certain Antibiotics Should Be Avoided for Shiga Toxin-Producing Escherichia coli Infections: More Data Needed.

  2016cites this paper
• Escherichia coli entérohémorragiques et/ou résistantes aux antibiotiques : contamination des effluents d'origine bovine

  2016cites this paper
• Shiga toxins and stx phages: highly diverse entities.

  2015influential citation
• Possible curative role of azithromycin administration in Escherichia coli-induced nephrotoxicity of young albino rats: histological, immunohistochemical, and morphometric study

  2015cites this paper
• Acute infectious diarrhea in immunocompetent adults.

  2014cites this paper
• Investigation of Encephalopathy Caused by Shiga Toxin 2c-Producing Escherichia coli Infection in Mice

  2013influential citation
• Different Effects of Six Antibiotics and Ten Traditional Chinese Medicines on Shiga Toxin Expression by Escherichia coli O157:H7

  2013influential citation
• EHEC-O104:H4-Ausbruch im Sommer 2011

  2013cites this paper
• Effects of Subinhibitory Concentrations of Antimicrobial Agents on Escherichia coli O157:H7 Shiga Toxin Release and Role of the SOS Response

  2013cites this paper
• Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis

  2013influential citation
• The effect of azithromycin on acute and chronic inflammation in an in vivo experimental model.

  2013cites this paper
• First isolation of non-O157 shiga toxin producing Escherichia coli in bovine and porcine meats in Venezuela

  2012cites this paper
• Approach to the patient with infectious colitis

  2012cites this paper
• The patient presenting with acute dysentery--a systematic review.

  2012cites this paper
• Primer aislamiento de Escherichia coli no O157 productor de toxina Shiga en carnes bovina y porcina en Venezuela

  2012cites this paper
• Versorgung und Behandlung von EHEC/HUS-Patienten

  2012cites this paper
• Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.

  2012cites this paper
• Management of community-acquired pneumonia in adults.

  2011cites this paper
• Bacteraemic Pneumococcal Pneumonia

  2011cites this paper
• Different Classes of Antibiotics Differentially Influence Shiga Toxin Production

  2010cites this paper
• Enhanced expression of ATP-binding cassette transporter A1 in non-rafts decreases the sensitivity of vascular endothelial cells to Shiga toxin.

  2010cites this paper
• [Expression and extracellular release of Shiga toxin in enterohemorrahgic Escherichia coli].

  2010cites this paper
• Different Classes of Antibiotics Differentially Influence Shiga Toxin Production (cid:1)

  2010cites this paper
• Clinical Guideline for the Diagnosis and Treatment of Gastrointestinal Infections

  2010cites this paper
• Azithromycin treatment modulates cytokine production in Chlamydia trachomatis infected women.

  2009cites this paper
• Clinical practice. Bacterial diarrhea.

  2009cites this paper
• Expert review of the evidence base for self-therapy of travelers' diarrhea.

  2009cites this paper
• Phage-Shaping Evolution of Bacterial Pathogenicity and Resistance

  2008cites this paper
• Prevention and treatment of enterohemorrhagic Escherichia coli infections in humans

  2008cites this paper
• Antimicrobial resistance among enteric pathogens.

  2008cites this paper
• Renal damage and death in weaned mice after oral infection with Shiga toxin 2‐producing Escherichia coli strains

  2008cites this paper
• The Non-O157 Shiga-Toxigenic (Verocytotoxigenic) Escherichia coli; Under-Rated Pathogens

  2007influential citation
• Rifaximin Does Not Induce Toxin Production or Phage-Mediated Lysis of Shiga Toxin-Producing Escherichia coli

  2007cites this paper
• Production of Shiga Toxin by a luxS Mutant of Escherichia coli O157:H7 In Vivo and In Vitro

  2007cites this paper
• Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages

  2006cites this paper
• Inhibitory effect of antimicrobial agents and anisodamine on the staphylococcal superantigenic toxin-induced overproduction of proinflammatory cytokines by human peripheral blood mononuclear cells

  2005cites this paper
• Significant reduction in inflammatory response in the macaque model of chlamydial pelvic inflammatory disease with azithromycin treatment.

  2005cites this paper
• Antimicrobial treatment of asymptomatic carriers of verocytotoxin-producing Escherichia coli: An empiric study

  2005cites this paper
• Global Expression of Prophage Genes in Escherichia coli O157:H7 Strain EDL933 in Response to Norfloxacin

  2005cites this paper
• A millennium update on pediatric diarrheal illness in the developing world.

  2005cites this paper
• Synthesis and antimicrobial activity of erythromycin-A oxime analogs.

  2004cites this paper
• The role of Shiga-toxin-producing Escherichia coli in hemorrhagic colitis and hemolytic uremic syndrome.

  2004cites this paper
• Antimicrobial resistance among enteric pathogens.

  2004cites this paper
• Epidemiology and spectrum of disease of Escherichia coli O157

  2003cites this paper
• 60Co irradiation of Shiga toxin (Stx)-producing Escherichia coli induces Stx phage.

  2003cites this paper
• Pathogenesis and Immune Response

  2002cites this paper